首页|感染性休克患者血清miR-16-5p和miR-155-5p表达水平及其与预后的关系

感染性休克患者血清miR-16-5p和miR-155-5p表达水平及其与预后的关系

扫码查看
目的 本研究旨在评估感染性休克患者血清miR-16-5p和miR-155-5p表达水平及其与预后的关系.方法 选取2021年6月至2023年7月长安医院急诊科收治的86例确诊为感染性休克的患者(男47例,女39例,<60岁45例,≥60岁41例),根据病情程度分为轻度组30例、中度组29例、重度组27例.对患者进行为期1个月的生存状况统计,基于生存情况将患者划分为死亡组20例和生存组66例.对比各组患者的临床资料,分析miR-16-5p和miR-155-5p表达水平与急性生理学和慢性健康状况评价(APACHE Ⅱ)评分的相关性,构建受试者操作特征曲线(ROC)分析血清miR-16-5p和miR-155-5p预测感染性休克患者预后的价值,logistic回归分析感染性休克患者预后不良的危险因素.采用独立样本t检验、F检验、x2检验、Pearson相关性分析.结果 重度组的心率(HR)、C反应蛋白(CRP)、APACHEⅡ评分、miR-16-5p和miR-155-5p表达水平均高于轻度组和中度组(均P<0.05),平均动脉压(MAP)、中心静脉压(CVP)、氧合指数(OI)均低于轻度组和中度组(均P<0.05).死亡组的CRP、APACHE Ⅱ评分、miR-16-5p和miR-155-5p表达水平均高于生存组(均P<0.05),OI低于生存组(P<0.05).Pearson相关性分析显示miR-16-5p和miR-155-5p表达水平与APACHE Ⅱ评分均呈正相关(r=0.509、0.722,均P<0.001).血清miR-16-5p联合miR-155-5p预测感染性休克患者预后不良的曲线下面积(AUC)为0.944,95%置信区间(CI)为0.894-0.994,灵敏度为90.0%,特异度为84.8%,显示出较高的预测效能.miR-16-5p和miR-155-5p均为感染性休克患者预后不良的危险因素[OR=10.608(2.275~49.461)、25.410(4.573~141.176),均 P<0.05].结论 在感染性休克患者中,血清miR-16-5p和miR-155-5p表达水平与病情严重程度和预后显著相关,这两种miRNA可作为感染性休克患者预后不良的生物标志物.
Expression levels of serum miR-16-5p and miR-155-5p and their relationships with prognosis in patients with infectious shock
Objective This study aimed to assess the serum levels of miR-16-5p and miR-155-5p in patients with infectious shock,and to explore their relationships with prognosis.Methods From June 2021 to July 2023,a total of 86 patients diagnosed with infectious shock were selected from the Emergency Department of Chang'an Hospital.There were 47 males and 39 females,45 cases<60 years old and 41 cases ≥60 years old.These patients were categorized into three groups based on the severity of their condition:mild(30 patients),moderate(29 patients),and severe degree(27 patients).Over a one-month period,the survival status of these patients was monitored,leading to the formation of two groups:a death group(20 patients)and a survival group(66 patients).Comparative analyses of clinical data were conducted across each group.The correlations between the expression levels of miR-16-5p and miR-155-5p and the Acute Physiology and Chronic Health Evaluation(APACHE Ⅱ)score were analyzed.The receiver operating characteristic curve(ROC)was constructed to assess the prognostic diagnostic values of serum miR-16-5p and miR-155-5p in infectious shock.The risk factors of poor prognosis in patients with infectious shock were analyzed by logistic regression analysis.Independent sample t test,F test,x2 test,and Pearson correlation analysis were used.Results The heart rate(HR),C-reactive protein(CRP),APACHE Ⅱ score,and expression levels of miR-16-5p and miR-155-5p in the severe group were higher than those in the mild and moderate groups(all P<0.05),but the mean arterial pressure(MAP),central venous pressure(CVP),and oxygenation index(OI)were lower than those in the mild and moderate groups(all P<0.05).The CRP,APACHE Ⅱ score,and expression levels of miR-16-5p and miR-155-5p in the death group were higher than those in the survival group(all P<0.05),but the OI was lower than that in the survival group(P<0.05).Pearson correlation analysis showed that the expression levels of miR-16-5p and miR-155-5p were positively correlated with APACHE Ⅱ score(r=0.509 and 0.722,both P<0.001).The area under the curve(AUC)of serum miR-16-5p combined with miR-155-5p in predicting poor prognosis in patients with infectious shock was 0.944,the 95%confidence interval(CI)was 0.894-0.994,the sensitivity was 90.0%,and the specificity was 84.8%,indicating high predictive efficacy.Both miR-16-5p and miR-155-5p were risk factors for poor prognosis in patients with infectious shock[OR=10.608(2.275-49.461)and 25.410(4.573-141.176),both P<0.05].Conclusion In patients with infectious shock,serum expression levels of miR-16-5p and miR-155-5p are significantly associated with the condition's severity and prognosis.Thus,these two miRNAs may serve as biomarkers for predicting poor prognosis in such patients.

Infectious shockmiR-16-5pmiR-155-5pPrognosisCorrelation

刘刚、原平利

展开 >

长安医院急诊科,西安 710016

武警陕西总队医院特色专业二科,西安 710054

感染性休克 miR-16-5p miR-155-5p 预后 相关性

陕西省重点研发计划

S2022-YF-YBSF-0781

2024

国际医药卫生导报
中华医学会,国际医药卫生导报社

国际医药卫生导报

影响因子:0.781
ISSN:1007-1245
年,卷(期):2024.30(10)
  • 29